论文信息 - Integrated Bioassays in Microfluidic Devices: Botulinum Toxin Assays

Integrated Bioassays in Microfluidic Devices: Botulinum Toxin Assays

A microfluidic assay was developed for screening botulinum neurotoxin serotype A (BoNT-A) by using a fluorescent resonance energy transfer (FRET) assay. Molded silicone microdevices with integral valves, pumps, and reagent reservoirs were designed and fabricated. 1-4Electrical and pneumatic control hardwarewere constructed, and softwarewaswritten to automate the assay protocol and data acquisition. Detection was accomplished by fluorescence microscopy. The system was validated with a peptide inhibitor, running 2 parallel assays, as a feasibility demonstration. The small footprint of each bioreactor cell (0.5cm2) and scalable fluidic architecture enabled many parallel assays on a single chip. The chip is programmable to run a dilution series in each lane, generating concentration-response data for multiple inhibitors. The assay results showed good agreement with the corresponding experiments done at a macroscale level. Although the system has been developed for BoNT-A screening, awide variety of assays can be performed on themicrofluidic chipwith little or nomodification.

[1] S. Quake,et al. From micro- to nanofabrication with soft materials. , 2000, Science.

[2] W. Thomas Shier,et al. Handbook of Toxinology , 1990 .

[3] F. Benfenati,et al. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. , 1993, The Journal of biological chemistry.

[4] James J. Schmidt,et al. A high‐affinity competitive inhibitor of type A botulinum neurotoxin protease activity , 2002, FEBS letters.

[5] G. Whitesides,et al. Microfabrication inside capillaries using multiphase laminar flow patterning , 1999, Science.

[6] H. Niemann,et al. Probing the mechanistic role of glutamate residue in the zinc-binding motif of type A botulinum neurotoxin light chain. , 2000, Biochemistry.

[7] G. Whitesides,et al. Soft lithography in biology and biochemistry. , 2001, Annual review of biomedical engineering.

[8] C. Millard,et al. High-throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F. , 2001, Analytical biochemistry.

[9] G. Schiavo,et al. Botulinum neurotoxins are zinc proteins. , 1992, The Journal of biological chemistry.

[10] Rick Gussio,et al. Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity. , 2003, Biochemical and biophysical research communications.